DSGN
Price
$7.36
Change
-$0.23 (-3.03%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
419.25M
117 days until earnings call
Intraday BUY SELL Signals
DYN
Price
$20.60
Change
-$0.36 (-1.72%)
Updated
Nov 19 closing price
Capitalization
2.94B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DSGN vs DYN

Header iconDSGN vs DYN Comparison
Open Charts DSGN vs DYNBanner chart's image
Design Therapeutics
Price$7.36
Change-$0.23 (-3.03%)
Volume$1.03K
Capitalization419.25M
Dyne Therapeutics
Price$20.60
Change-$0.36 (-1.72%)
Volume$1.99M
Capitalization2.94B
DSGN vs DYN Comparison Chart in %
DSGN
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DSGN vs. DYN commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Hold and DYN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (DSGN: $7.36 vs. DYN: $20.61)
Brand notoriety: DSGN and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 78% vs. DYN: 72%
Market capitalization -- DSGN: $419.25M vs. DYN: $2.94B
DSGN [@Biotechnology] is valued at $419.25M. DYN’s [@Biotechnology] market capitalization is $2.94B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 3 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 4 bearish.
  • DYN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than DYN.

Price Growth

DSGN (@Biotechnology) experienced а -3.29% price change this week, while DYN (@Biotechnology) price change was +10.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

DSGN is expected to report earnings on Mar 17, 2026.

DYN is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($2.94B) has a higher market cap than DSGN($419M). DSGN YTD gains are higher at: 19.287 vs. DYN (-12.521). DSGN has higher annual earnings (EBITDA): -74.31M vs. DYN (-437.37M). DYN has more cash in the bank: 684M vs. DSGN (216M). DSGN has less debt than DYN: DSGN (1.95M) vs DYN (121M). DSGN (0) and DYN (0) have equivalent revenues.
DSGNDYNDSGN / DYN
Capitalization419M2.94B14%
EBITDA-74.31M-437.37M17%
Gain YTD19.287-12.521-154%
P/E RatioN/AN/A-
Revenue00-
Total Cash216M684M32%
Total Debt1.95M121M2%
TECHNICAL ANALYSIS
Technical Analysis
DSGNDYN
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
DSGN
Daily Signal:
Gain/Loss:
DYN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BDAFX31.630.25
+0.80%
Baron Durable Advantage Retail
THOAX47.170.08
+0.17%
Thornburg Global Opportunities A
PIIMX33.98N/A
N/A
Principal Glb Emerging Markets R6
VYSZX5.83N/A
N/A
Voya MI Dynamic Small Cap C
FHUMX14.56N/A
N/A
Federated Hermes US SMID Institutional

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
-3.03%
IDYA - DSGN
51%
Loosely correlated
-1.72%
DYN - DSGN
50%
Loosely correlated
-1.67%
RNA - DSGN
48%
Loosely correlated
+0.06%
CRNX - DSGN
46%
Loosely correlated
-0.23%
WVE - DSGN
46%
Loosely correlated
-3.23%
More